RecruitingNCT07298083
DoD Award NF230020 Identification of Metabolic Markers and Statistical Prediction of MPNST for Rapid Diagnosis and Assessment of Surgical Margins
Sponsor
M.D. Anderson Cancer Center
Enrollment
60 participants
Start Date
Apr 2, 2026
Study Type
OBSERVATIONAL
Conditions
Summary
The goal of this clinical research study is to learn if a handheld Mass Spectrometry device (MasSpec Pen) can accurately distinguish between masses, neurofibroma, and normal tissue during surgery.
Eligibility
Min Age: 1 Year
Plain Language Summary
Simplified for easier understanding
This clinical trial is studying a new treatment for people with mpnst and neurofibromas. The study is currently recruiting participants at 1 location. People eligible for this study include aged 1 Year and older.
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07298083